-
公开(公告)号：US20240335652A1
公开(公告)日：2024-10-10
申请号：US18627983
申请日：2024-04-05
IPC分类号： A61M60/882 , A61M60/178 , A61M60/268 , A61M60/424 , A61M60/837 , A61M60/857 , A61N1/36
CPC分类号： A61M60/882 , A61M60/178 , A61M60/268 , A61M60/424 , A61M60/837 , A61M60/857 , A61M2205/054 , A61N1/36003
摘要： An autologous left ventricular assist device (ALVAD) is implanted into a skeletal muscle of a patient, such as being nested in the Latissimus Dorsi muscle. This implantation may be referred to as a training or prefabrication step and may last for 3 to 6 months or even longer. The ALVAD may include a plurality of ribs distributed in a spiral configuration as structural support and may include a plurality of electrodes operative to cause repeated contractions of the latissimus dorsi muscle. Once trained, the autologous LVAD—now integrated into the conditioned muscle—may be repositioned, reshaped and, specifically, moved into proximity with the patient's own heart and operatively coupled in fluid communication therewith for repeatedly contracting so as to pump oxygenated blood to and through the aorta and to the patient's organs and tissues.
-
2.发明公开公开(公告)号：US20240335649A1
公开(公告)日：2024-10-10
申请号：US18380206
申请日：2022-04-18
IPC分类号： A61M60/523 , A61M31/00 , A61M60/178 , A61M60/232 , A61M60/237 , A61M60/258 , A61M60/405 , A61M60/427 , A61M60/531 , A61M60/873 , A61M60/876 , A61N1/05 , A61N1/39
CPC分类号： A61M60/523 , A61M31/002 , A61M60/178 , A61M60/232 , A61M60/237 , A61M60/258 , A61M60/405 , A61M60/427 , A61M60/531 , A61M60/873 , A61M60/876 , A61N1/0587 , A61N1/3962 , A61M2205/054 , A61M2205/3523 , A61M2230/04
摘要： The present invention helps in enabling cardiac recovery in patients with heart failure and for facilitating cardiac muscle regeneration by long term augmentation of the coronary perfusion pressure and thereby the coronary blood flow by using an implantable, preferably self-contained electrically operated pump which takes the oxygen rich blood from one of the chambers of the heart or a large blood vessel, that include the aorta, the subclavian artery, left atrium, one or more pulmonary veins, etc and pumps it into a singular or multitude of coronary arteries through a natural (autologous, homologous or heterologous) or synthetic ‘conduit’, a medium to long term inotropic support to the heart, through a dedicated channel to deliver inotropic and other medicines and stem cells directly into the coronary circulation, where one end of the channel typically ends outside the body and the other end rests inside the lumen of the ‘conduit’ which supplies the oxygenated blood into the coronary arteries; a central processing unit (CPU) with an integrated defibrillator to monitor and control pump speed and flow rates; an implantable power source for the pump which can be charged transcutaneously using an external wireless system (‘TET’: transcutaneous energy transfer systems), to power the pump and the CPU.
-
公开(公告)号：US12070596B2
公开(公告)日：2024-08-27
申请号：US16982713
申请日：2019-03-19
申请人： COCHLEAR LIMITED
发明人： Daniel Smyth
CPC分类号： A61N1/0541 , A61M5/1723 , A61N1/36038 , A61M2005/1726 , A61M2205/054 , A61M2210/0662
摘要： An apparatus, such as an implantable medical device, including an implantable device configured to cause trauma in an inner ear and/or a middle ear recipient. In an exemplary embodiment, the implantable device is a cochlear implant. In an exemplary embodiment, the implantable device is configured to deliver a therapeutic substance to body tissue of the recipient.
-
公开(公告)号：US11986631B2
公开(公告)日：2024-05-21
申请号：US16928251
申请日：2020-07-14
申请人： Medtronic, Inc.
发明人： Martin T. Gerber , John C. Rondoni
IPC分类号： A61N1/36 , A61M5/172 , A61N1/372 , G16H20/10 , G16H20/30 , G16H40/20 , G16H40/63 , G16H50/50 , A61M5/142
CPC分类号： A61M5/1723 , A61N1/36034 , A61N1/36185 , A61N1/37235 , A61N1/37247 , A61N1/37264 , G16H20/10 , G16H20/30 , G16H40/20 , G16H40/63 , G16H50/50 , A61M5/14276 , A61M2205/054 , A61M2210/0693 , A61N1/36003 , A61N1/36007 , A61N1/36071 , A61N1/36082
摘要： Techniques for modeling therapy fields for therapy delivered by medical devices are described. Each therapy field model is based on a set of therapy parameters and represents where therapy will propagate from the therapy system delivering therapy according to the set of therapy parameters. Therapy field models may be useful in guiding the modification of therapy parameters. As one example, a processor compares an algorithmic model of a therapy field to a reference therapy field and adjusts at least one therapy parameter based on the comparison. As another example, a processor adjusts at least one therapy parameter to increase an operating efficiency of the therapy system while substantially maintaining the modeled therapy field.
-
公开(公告)号：US20240050743A1
公开(公告)日：2024-02-15
申请号：US18229305
申请日：2023-08-02
CPC分类号： A61N1/3601 , A61M16/0003 , A61N1/0553 , A61N1/36139 , A61N1/37247 , A61N1/0502 , A61N1/37258 , A61M2205/054
摘要： A number of systems and methods described here are directed to controlling, activating, and otherwise interacting with the phrenic nerve of a patient while the patient is undergoing mechanical ventilation, thus interacting with the diaphragm. Some embodiments of the systems and methods described herein are configured to achieve phrenic nerve stimulation in a controlled manner so as to sufficiently adapt the breathing therapy to a variety of patients.
-
6.发明授权公开(公告)号：US11865037B2
公开(公告)日：2024-01-09
申请号：US17171285
申请日：2021-02-09
发明人： Robert D. Black , Lanty L. Smith , Lesco L. Rogers
IPC分类号： A61N1/04 , A61N1/36 , A61M21/02 , A61F7/12 , A61B6/03 , A61N1/05 , A61F7/00 , H04R1/10 , A61M21/00 , A61N1/32
CPC分类号： A61F7/12 , A61B6/037 , A61F7/007 , A61M21/02 , A61N1/0456 , A61N1/0484 , A61N1/0526 , A61N1/36021 , A61N1/36025 , A61N1/36028 , A61N1/36031 , A61N1/36034 , H04R1/1016 , H04R1/1091 , A61F2007/0005 , A61F2007/0075 , A61F2007/0093 , A61F2007/126 , A61M2021/0027 , A61M2021/0072 , A61M2021/0077 , A61M2205/054 , A61M2210/0662 , A61N1/327 , H04R1/10 , H04R2460/13
摘要： A method of galvanic vestibular stimulation (GVS) may include delivering an electrical signal via transdermal electrical stimulation using a plurality of electrodes connected to a patient. The electrical signal may include an amplitude and a carrier frequency. The method may include modulating at least one of the amplitude and the carrier frequency based on a modulation waveform to modulate the electrical signal, the modulation waveform may include a modulation frequency that is less than the carrier frequency.
-
公开(公告)号：US20230321417A1
公开(公告)日：2023-10-12
申请号：US18297766
申请日：2023-04-10
申请人： HeartHero, Inc.
发明人： Gary Montague , Anthony Verdeja
CPC分类号： A61M35/006 , A61N1/3904 , A61N1/046 , A61N1/0496 , A61M2205/054 , A61M2037/0023
摘要： An automated external defibrillator (AED) system includes shock generating electronics configured to provide at least one electrical shock suitable for a patient experiencing a cardiac event, a battery configured for providing power to the shock generating electronics, power management circuitry configured for managing the shock generating electronics and the battery, a single microprocessor configured for controlling the power management circuitry, and an enclosure configured to house the shock generating electronics, the battery, the power management circuitry, and the single microprocessor. In an embodiment, the AED system includes at least two cardiac pads in electrical connection with the shock generating electronics and including a medication delivery mechanism configured for delivering a predetermined dose of a medication to a patient when the cardiac pads are placed on the patient for shock delivery.
-
公开(公告)号：US11759368B2
公开(公告)日：2023-09-19
申请号：US17351749
申请日：2021-06-18
申请人： Aatru Medical, LLC
发明人： Russell S. Donda , Sundar Manickam , Richard L. Middaugh , Thomas E. Lash , Timothy Wojciechowski , John D. Wolter , John Buan
IPC分类号： A61F13/00 , A61F13/02 , A61M27/00 , A61M37/00 , A61N1/04 , A61N1/36 , A61M35/00 , A61M1/00 , A61H9/00 , A61N5/06
CPC分类号： A61F13/00068 , A61F13/00 , A61F13/00063 , A61F13/02 , A61H9/0057 , A61H9/0071 , A61M1/60 , A61M1/80 , A61M1/92 , A61M1/962 , A61M1/985 , A61M27/00 , A61M35/30 , A61M37/00 , A61N1/0492 , A61N1/36014 , A61H2201/0278 , A61H2201/105 , A61H2201/1238 , A61H2201/165 , A61M1/964 , A61M2205/0277 , A61M2205/051 , A61M2205/054 , A61M2205/364 , A61N5/0616 , A61N2005/0652
摘要： A wound therapy device and method includes a skin contacting element, a reactor, and a reactor housing element. The skin contacting element is configured for covering an associated tissue site, the reactor for creating a pressure condition at the associated tissue site upon actuation thereof, and the reactor housing element for accommodating the reactor. The skin contacting element has a skin contacting side and an interface side, which is opposite the skin contacting side. The reactor housing element has a lower affixing side and an upper side, which is opposite the lower affixing side.
-
公开(公告)号：US11701253B2
公开(公告)日：2023-07-18
申请号：US17315542
申请日：2021-05-10
发明人： Robert D. Black , Lanty L. Smith , Lesco L. Rogers
IPC分类号： A61F7/12 , A61N1/04 , A61N1/36 , A61B6/03 , A61N1/05 , A61F7/00 , A61M21/02 , H04R1/10 , A61M21/00 , A61N1/32
CPC分类号： A61F7/12 , A61B6/037 , A61F7/007 , A61M21/02 , A61N1/0456 , A61N1/0484 , A61N1/0526 , A61N1/36021 , A61N1/36025 , A61N1/36028 , A61N1/36031 , A61N1/36034 , H04R1/1016 , H04R1/1091 , A61F2007/0005 , A61F2007/0075 , A61F2007/0093 , A61F2007/126 , A61M2021/0027 , A61M2021/0072 , A61M2021/0077 , A61M2205/054 , A61M2210/0662 , A61N1/327 , H04R1/10 , H04R2460/13
摘要： A vestibular neurostimulation device, which may include first and second electrodes; first and second thermoelectric devices thermally coupled, respectively, to first and second earpieces that are configured to be insertable into respective ear canals of a patient; and a controller comprising a waveform generator. The waveform generator may be is configured to deliver a modulated electric signal to the patient through galvanic vestibular stimulation (GVS) using the first and second electrodes and to deliver a time varying thermal waveform to the patient through caloric vestibular stimulation (CVS) using the first and second earpieces simultaneous with the delivery of the modulated electrical signal through GVS. The CVS and/or GVS may be configured to increase a passage of insulin-like growth factor 1 (IGF-1) through a blood-brain-barrier.
-
公开(公告)号：US20190060540A1
公开(公告)日：2019-02-28
申请号：US16172041
申请日：2018-10-26
申请人： HeartWare, Inc.
发明人： Barry M. YOMTOV
CPC分类号： A61M1/1086 , A61M1/10 , A61M1/1005 , A61M1/101 , A61M1/1029 , A61M1/1034 , A61M1/122 , A61M1/125 , A61M1/127 , A61M2205/054 , A61M2205/3303 , A61M2205/3334 , A61M2205/3515 , A61M2205/3538 , A61M2205/3592 , A61M2205/50 , A61M2205/8243 , A61M2230/04 , A61N1/3627 , A61N1/3962 , H05K999/99
摘要： A ventricular assist device incorporating a rotary pump, such as a rotary impeller pump is implantable in fluid communication with a ventricle and an artery to assist blood flow from the ventricle to the artery. The device includes a pump drive circuit supplying power to the pump, one or more sensors for sensing one or more electrophysiological signals such as electrogram signals in and a signal processing circuit connected to the sensors and the pump drive circuit. The signal processing circuit is operative to detect the sensor signals and control power supplied to the pump from the pump drive circuit so that the pump runs in a pulsatile mode, with a varying speed synchronized with the cardiac cycle. When an arrhythmia is detected, the pump drive circuit may also run the pump in an atrial arrhythmia mode or a ventricular arrhythmia mode different from the normal pulsatile mode.
-
-
-
-
-
-
-
-
-
搜索结果
362 条记录 (耗时 0.035 秒)
